187 related articles for article (PubMed ID: 19305643)
1. The role of SRC-1 in murine prostate cancinogenesis is nonessential due to a possible compensation of SRC-3/AIB1 overexpression.
Tien JC; Zhou S; Xu J
Int J Biol Sci; 2009; 5(3):256-64. PubMed ID: 19305643
[TBL] [Abstract][Full Text] [Related]
2. Genetic ablation of the amplified-in-breast cancer 1 inhibits spontaneous prostate cancer progression in mice.
Chung AC; Zhou S; Liao L; Tien JC; Greenberg NM; Xu J
Cancer Res; 2007 Jun; 67(12):5965-75. PubMed ID: 17575167
[TBL] [Abstract][Full Text] [Related]
3. ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes.
Zou JX; Zhong Z; Shi XB; Tepper CG; deVere White RW; Kung HJ; Chen H
Prostate; 2006 Oct; 66(14):1474-86. PubMed ID: 16921507
[TBL] [Abstract][Full Text] [Related]
4. SRC-3/AIB1: transcriptional coactivator in oncogenesis.
Yan J; Tsai SY; Tsai MJ
Acta Pharmacol Sin; 2006 Apr; 27(4):387-94. PubMed ID: 16539836
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of androgen receptor coactivators in prostate cancer.
Culig Z; Comuzzi B; Steiner H; Bartsch G; Hobisch A
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):265-71. PubMed ID: 15663989
[TBL] [Abstract][Full Text] [Related]
6. Role of the steroid receptor coactivator SRC-3 in cell growth.
Zhou G; Hashimoto Y; Kwak I; Tsai SY; Tsai MJ
Mol Cell Biol; 2003 Nov; 23(21):7742-55. PubMed ID: 14560019
[TBL] [Abstract][Full Text] [Related]
7. SRC-3 is required for prostate cancer cell proliferation and survival.
Zhou HJ; Yan J; Luo W; Ayala G; Lin SH; Erdem H; Ittmann M; Tsai SY; Tsai MJ
Cancer Res; 2005 Sep; 65(17):7976-83. PubMed ID: 16140970
[TBL] [Abstract][Full Text] [Related]
8. Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.
Boorjian SA; Heemers HV; Frank I; Farmer SA; Schmidt LJ; Sebo TJ; Tindall DJ
Endocr Relat Cancer; 2009 Mar; 16(1):123-37. PubMed ID: 18845648
[TBL] [Abstract][Full Text] [Related]
9. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
[TBL] [Abstract][Full Text] [Related]
10. Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1.
Liao L; Kuang SQ; Yuan Y; Gonzalez SM; O'Malley BW; Xu J
J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):3-14. PubMed ID: 12650696
[TBL] [Abstract][Full Text] [Related]
11. Differential gene regulation by the SRC family of coactivators.
Zhang H; Yi X; Sun X; Yin N; Shi B; Wu H; Wang D; Wu G; Shang Y
Genes Dev; 2004 Jul; 18(14):1753-65. PubMed ID: 15256502
[TBL] [Abstract][Full Text] [Related]
12. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
[TBL] [Abstract][Full Text] [Related]
13. Review of the in vivo functions of the p160 steroid receptor coactivator family.
Xu J; Li Q
Mol Endocrinol; 2003 Sep; 17(9):1681-92. PubMed ID: 12805412
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells.
Oh AS; Lahusen JT; Chien CD; Fereshteh MP; Zhang X; Dakshanamurthy S; Xu J; Kagan BL; Wellstein A; Riegel AT
Mol Cell Biol; 2008 Nov; 28(21):6580-93. PubMed ID: 18765637
[TBL] [Abstract][Full Text] [Related]
15. Activated polyamine catabolism depletes acetyl-CoA pools and suppresses prostate tumor growth in TRAMP mice.
Kee K; Foster BA; Merali S; Kramer DL; Hensen ML; Diegelman P; Kisiel N; Vujcic S; Mazurchuk RV; Porter CW
J Biol Chem; 2004 Sep; 279(38):40076-83. PubMed ID: 15252047
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.
Tilli MT; Reiter R; Oh AS; Henke RT; McDonnell K; Gallicano GI; Furth PA; Riegel AT
Mol Endocrinol; 2005 Mar; 19(3):644-56. PubMed ID: 15550471
[TBL] [Abstract][Full Text] [Related]
17. Generation and validation of a mouse line with a floxed SRC-3/AIB1 allele for conditional knockout.
Liu Z; Liao L; Zhou S; Xu J
Int J Biol Sci; 2008 Jul; 4(4):202-7. PubMed ID: 18690289
[TBL] [Abstract][Full Text] [Related]
18. Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase.
Wu RC; Qin J; Hashimoto Y; Wong J; Xu J; Tsai SY; Tsai MJ; O'Malley BW
Mol Cell Biol; 2002 May; 22(10):3549-61. PubMed ID: 11971985
[TBL] [Abstract][Full Text] [Related]
19. The steroid receptor coactivator-3 is required for developing neuroendocrine tumor in the mouse prostate.
Tien JC; Liao L; Liu Y; Liu Z; Lee DK; Wang F; Xu J
Int J Biol Sci; 2014; 10(10):1116-27. PubMed ID: 25332686
[TBL] [Abstract][Full Text] [Related]
20. The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice.
Fereshteh MP; Tilli MT; Kim SE; Xu J; O'Malley BW; Wellstein A; Furth PA; Riegel AT
Cancer Res; 2008 May; 68(10):3697-706. PubMed ID: 18483252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
